You're going to hear a lot more about "ASA resistance"

You're going to hear a lot more about "ASA resistance." Now that millions of people take low-dose ASA to prevent cardiovascular disease, we're seeing that it doesn't always work.

About 10% of the population might be resistant to ASA's antiplatelet effects. These patients might be up to 3 times more likely to die of cardiovascular disease.

Two tests for ASA resistance are already on the market... AspirinCheck and AspirinWorks.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote